{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:49:44Z","timestamp":1791503384171,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research on the Regulation of Autophagy in Glioma by LncRNA TSIX and Its Mechanism","award":["2019WS323"],"award-info":[{"award-number":["2019WS323"]}]},{"name":"Yantai Natural Science Foundation Biomedical Innovation Joint Fund Project for 2025","award":["ZR2025LZ051"],"award-info":[{"award-number":["ZR2025LZ051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00898-x","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:46:04Z","timestamp":1784047564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into TXNDC17-mediated ferroptosis suppression in glioblastoma progression"],"prefix":"10.1186","volume":"21","author":[{"given":"Zixuan","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"5","key":"898_CR1","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.3390\/ijms25053040","volume":"25","author":"Z Lan","year":"2024","unstructured":"Lan Z, Li X, Zhang X, Glioblastoma. An update in pathology, molecular mechanisms and biomarkers. Int J Mol Sci. 2024;25(5):3040. https:\/\/doi.org\/10.3390\/ijms25053040.","journal-title":"Int J Mol Sci"},{"issue":"27","key":"898_CR2","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/s41388-023-02738-y","volume":"42","author":"D Eisenbarth","year":"2023","unstructured":"Eisenbarth D, Wang YA. Glioblastoma heterogeneity at single cell resolution. Oncogene. 2023;42(27):2155\u201365. https:\/\/doi.org\/10.1038\/s41388-023-02738-y.","journal-title":"Oncogene"},{"issue":"8","key":"898_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro-Oncol. 2021;23(8):1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neuro-Oncol"},{"key":"898_CR4","doi-asserted-by":"publisher","unstructured":"Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: Heterogeneity, plasticity, and therapy. J Clin Invest. 2023;133(1). https:\/\/doi.org\/10.1172\/jci163446.","DOI":"10.1172\/jci163446"},{"issue":"1","key":"898_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/neuonc\/noac099","volume":"25","author":"A Omuro","year":"2023","unstructured":"Omuro A, Brandes AA, Carpentier AF, et al. Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial. Neuro-Oncol. 2023;25(1):123\u201334. https:\/\/doi.org\/10.1093\/neuonc\/noac099.","journal-title":"Neuro-Oncol"},{"issue":"6","key":"898_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342. https:\/\/doi.org\/10.1038\/s41580-024-00703-5.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"898_CR7","doi-asserted-by":"publisher","unstructured":"Zhou Q, Meng Y, Li D, Zhang X, Wang Y, Liu J, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9(1):59. https:\/\/doi.org\/10.1038\/s41392-024-01769-5.","DOI":"10.1038\/s41392-024-01769-5"},{"key":"898_CR8","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z. GPX4, ferroptosis, and diseases. Biomed Pharmacother. 2024;174:116512. https:\/\/doi.org\/10.1016\/j.biopha.2024.116512.","journal-title":"Biomed Pharmacother"},{"key":"898_CR9","doi-asserted-by":"publisher","unstructured":"Huang B, Wang H, Liu S, et al. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat Commun. 2025;16(1). https:\/\/doi.org\/10.1038\/s41467-025-56344-5.","DOI":"10.1038\/s41467-025-56344-5"},{"key":"898_CR10","doi-asserted-by":"publisher","first-page":"115021","DOI":"10.1016\/j.jep.2022.115021","volume":"289","author":"C Fu","year":"2022","unstructured":"Fu C, Wu Y, Liu S, et al. Rehmannioside a improves cognitive impairment and alleviates ferroptosis via activating PI3K\/AKT\/Nrf2 and SLC7A11\/GPX4 signaling pathway after ischemia. J Ethnopharmacol. 2022;289:115021. https:\/\/doi.org\/10.1016\/j.jep.2022.115021.","journal-title":"J Ethnopharmacol"},{"key":"898_CR11","doi-asserted-by":"publisher","unstructured":"Zhang W, Gong M, Zhang W, et al. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death Dis. 2022;13(7). https:\/\/doi.org\/10.1038\/s41419-022-05082-3.","DOI":"10.1038\/s41419-022-05082-3"},{"key":"898_CR12","doi-asserted-by":"publisher","unstructured":"Kim JW, Min DW, Kim D, et al. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis. Sci Rep. 2023;13(1). https:\/\/doi.org\/10.1038\/s41598-023-35978-9.","DOI":"10.1038\/s41598-023-35978-9"},{"issue":"7","key":"898_CR13","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1172\/jci129049","volume":"130","author":"TTT Nguyen","year":"2020","unstructured":"Nguyen TTT, Zhang Y, Shang E, et al. HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models. J Clin Invest. 2020;130(7):3699\u2013716. https:\/\/doi.org\/10.1172\/jci129049.","journal-title":"J Clin Invest"},{"issue":"7","key":"898_CR14","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.62347\/tkfv8564","volume":"14","author":"J Xiao","year":"2024","unstructured":"Xiao J. TRIM27 promotes the warburg effect and glioblastoma progression via inhibiting the LKB1\/AMPK\/mTOR axis. Am J Cancer Res. 2024;14(7):3468\u201382. https:\/\/doi.org\/10.62347\/tkfv8564.","journal-title":"Am J Cancer Res"},{"key":"898_CR15","doi-asserted-by":"publisher","unstructured":"Yan Y, Zhou S, Chen X, et al. Suppression of ITPKB degradation by trim25 confers TMZ resistance in glioblastoma through ROS homeostasis. Signal Transduct Target Ther. 2024;9(1). https:\/\/doi.org\/10.1038\/s41392-024-01763-x.","DOI":"10.1038\/s41392-024-01763-x"},{"issue":"21","key":"898_CR16","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/cells12212522","volume":"12","author":"Y Wu","year":"2023","unstructured":"Wu Y, Franzmeier S, Liesche-Starnecker F, Schlegel J. Enhanced sensitivity to ALDH1A3-dependent ferroptosis in TMZ-resistant glioblastoma cells. Cells. 2023;12(21):2522. https:\/\/doi.org\/10.3390\/cells12212522.","journal-title":"Cells"},{"key":"898_CR17","doi-asserted-by":"publisher","unstructured":"Zhang J, Li X, Zhao Z, Cai W, Fang J. Thioredoxin signaling pathways in cancer. Antioxid Redox Signal. Published online August. 2022;9. https:\/\/doi.org\/10.1089\/ars.2022.0074.","DOI":"10.1089\/ars.2022.0074"},{"issue":"9","key":"898_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/antiox13091078","volume":"13","author":"R Seitz","year":"2024","unstructured":"Seitz R, T\u00fcmen D, Kunst C, et al. Exploring the thioredoxin system as a therapeutic target in cancer: Mechanisms and implications. Antioxidants. 2024;13(9):1078. https:\/\/doi.org\/10.3390\/antiox13091078.","journal-title":"Antioxidants"},{"key":"898_CR19","doi-asserted-by":"publisher","unstructured":"Muri J, Kopf M. The thioredoxin system: Balancing redox responses in immune cells and tumors. Eur J Immunol. 2023;53(1). https:\/\/doi.org\/10.1002\/eji.202249948.","DOI":"10.1002\/eji.202249948"},{"issue":"3","key":"898_CR20","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1002\/cam4.5169","volume":"12","author":"B Kocat\u00fcrk","year":"2023","unstructured":"Kocat\u00fcrk B. Identification of thioredoxin domain containing family members\u2019 expression pattern and prognostic value in diffuse gliomas via in silico analysis. Cancer Med. 2023;12(3):3830\u201344. https:\/\/doi.org\/10.1002\/cam4.5169.","journal-title":"Cancer Med"},{"issue":"1","key":"898_CR21","doi-asserted-by":"publisher","first-page":"102049","DOI":"10.1016\/j.xpro.2023.102049","volume":"4","author":"A Chen","year":"2023","unstructured":"Chen A, Chao Y, Zou H, McCarl LH, Kohanbash G, Hu B. Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models. STAR Protoc. 2023;4(1):102049. https:\/\/doi.org\/10.1016\/j.xpro.2023.102049.","journal-title":"STAR Protoc"},{"key":"898_CR22","doi-asserted-by":"publisher","first-page":"103032","DOI":"10.1016\/j.redox.2024.103032","volume":"70","author":"B Yang","year":"2024","unstructured":"Yang B, Lin Y, Huang Y, Shen YQ, Chen Q. Thioredoxin (trx): A redox target and modulator of cellular senescence and aging-related diseases. Redox Biol. 2024;70:103032. https:\/\/doi.org\/10.1016\/j.redox.2024.103032.","journal-title":"Redox Biol"},{"key":"898_CR23","doi-asserted-by":"publisher","first-page":"111004","DOI":"10.1016\/j.cbi.2024.111004","volume":"395","author":"MS Hsieh","year":"2024","unstructured":"Hsieh MS, Ling HH, Setiawan SA, et al. Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer. Chem Biol Interact. 2024;395:111004. https:\/\/doi.org\/10.1016\/j.cbi.2024.111004.","journal-title":"Chem Biol Interact"},{"key":"898_CR24","doi-asserted-by":"publisher","unstructured":"Scherschel M, Niemeier JO, Jacobs LJHC, et al. A family of NADPH\/NADP+ biosensors reveals in vivo dynamics of central redox metabolism across eukaryotes. Nat Commun. 2024;15(1). https:\/\/doi.org\/10.1038\/s41467-024-55302-x.","DOI":"10.1038\/s41467-024-55302-x"},{"issue":"2","key":"898_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: Molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"issue":"2","key":"898_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.14336\/ad.2023.0717","volume":"15","author":"F Feng","year":"2024","unstructured":"Feng F, He S, Li X, He J, Luo L. Mitochondria-mediated ferroptosis in diseases therapy: From molecular mechanisms to implications. Aging Dis. 2024;15(2):714. https:\/\/doi.org\/10.14336\/ad.2023.0717.","journal-title":"Aging Dis"},{"issue":"12","key":"898_CR27","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H, Lathia JD, Chen P. Immunotherapy for glioblastoma: Current state, challenges, and future perspectives. Cell Mol Immunol. 2024;21(12):1354\u201375. https:\/\/doi.org\/10.1038\/s41423-024-01226-x.","journal-title":"Cell Mol Immunol"},{"key":"898_CR28","doi-asserted-by":"publisher","unstructured":"Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol OncolJ Hematol Oncol. 2024;17(1). https:\/\/doi.org\/10.1186\/s13045-024-01544-7.","DOI":"10.1186\/s13045-024-01544-7"},{"key":"898_CR29","doi-asserted-by":"publisher","unstructured":"White J, White MPJ, Wickremesekera A, Peng L, Gray C. The tumour microenvironment, treatment resistance and recurrence in glioblastoma. J Transl Med. 2024;22(1). https:\/\/doi.org\/10.1186\/s12967-024-05301-9.","DOI":"10.1186\/s12967-024-05301-9"},{"issue":"32","key":"898_CR30","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3760\/cma.j.cn112137-20220614-01317","volume":"102","author":"QH Peng","year":"2022","unstructured":"Peng QH, Yu Y, Cheng XD, et al. [TXNDC17 protein overexpression in uterine papillary serous carcinoma is associated with clinicopathological characteristics and prognosis]. Zhonghua Yi Xue Za Zhi. 2022;102(32):2506\u201312. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20220614-01317.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"11","key":"898_CR31","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1021\/acs.jproteome.3c00749","volume":"23","author":"A Montero-Calle","year":"2024","unstructured":"Montero-Calle A, Garranzo-Asensio M, Poves C, et al. In-depth proteomic analysis of paraffin-embedded tissue samples from colorectal cancer patients revealed TXNDC17 and SLC8A1 as key proteins associated with the disease. J Proteome Res. 2024;23(11):4802\u201320. https:\/\/doi.org\/10.1021\/acs.jproteome.3c00749.","journal-title":"J Proteome Res"},{"key":"898_CR32","doi-asserted-by":"publisher","unstructured":"Zeng C, Li Z, Wei Z, et al. Mechanism of drug resistance to first-line chemotherapeutics mediated by TXNDC17\u2009in neuroblastomas. Cancer Rep. 2024;7(10). https:\/\/doi.org\/10.1002\/cnr2.70033.","DOI":"10.1002\/cnr2.70033"},{"issue":"13","key":"898_CR33","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1038\/s44318-024-00117-1","volume":"43","author":"P Mart\u00ed-Andr\u00e9s","year":"2024","unstructured":"Mart\u00ed-Andr\u00e9s P, Finamor I, Torres-Cuevas I, et al. TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. EMBO J. 2024;43(13):2789\u2013812. https:\/\/doi.org\/10.1038\/s44318-024-00117-1.","journal-title":"EMBO J"},{"key":"898_CR34","doi-asserted-by":"publisher","unstructured":"D\u00f3ka \u00c9, Ida T, Dagnell M, et al. Control of protein function through oxidation and reduction of persulfidated states. Sci Adv. 2020;6(1). https:\/\/doi.org\/10.1126\/sciadv.aax8358.","DOI":"10.1126\/sciadv.aax8358"},{"issue":"5","key":"898_CR35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"898_CR36","doi-asserted-by":"publisher","first-page":"114597","DOI":"10.1016\/j.intimp.2025.114597","volume":"155","author":"R Nedaeinia","year":"2025","unstructured":"Nedaeinia R, Dianat-Moghadam H, Movahednasab M, et al. Therapeutic and prognostic values of ferroptosis signature in glioblastoma. Int Immunopharmacol. 2025;155:114597. https:\/\/doi.org\/10.1016\/j.intimp.2025.114597.","journal-title":"Int Immunopharmacol"},{"key":"898_CR37","doi-asserted-by":"publisher","first-page":"217392","DOI":"10.1016\/j.canlet.2024.217392","volume":"611","author":"A Carlos","year":"2025","unstructured":"Carlos A, Mendes M, Cruz MT, Pais A, Vitorino C. Ferroptosis driven by nanoparticles for tackling glioblastoma. Cancer Lett. 2025;611:217392. https:\/\/doi.org\/10.1016\/j.canlet.2024.217392.","journal-title":"Cancer Lett"},{"key":"898_CR38","doi-asserted-by":"publisher","first-page":"122913","DOI":"10.1016\/j.biomaterials.2024.122913","volume":"315","author":"MF Wang","year":"2025","unstructured":"Wang MF, Guo J, Yuan SJ, et al. Targeted sonodynamic therapy induces tumor cell quasi-immunogenic ferroptosis and macrophage immunostimulatory autophagy in glioblastoma. Biomaterials. 2025;315:122913. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122913.","journal-title":"Biomaterials"},{"issue":"9","key":"898_CR39","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","volume":"26","author":"E Dai","year":"2024","unstructured":"Dai E, Chen X, Linkermann A, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 2024;26(9):1447\u201357. https:\/\/doi.org\/10.1038\/s41556-024-01360-8.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"898_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","volume":"105","author":"J Zheng","year":"2025","unstructured":"Zheng J, Conrad M, Ferroptosis. When metabolism meets cell death. Physiol Rev. 2025;105(2):651\u2013706. https:\/\/doi.org\/10.1152\/physrev.00031.2024.","journal-title":"Physiol Rev"},{"issue":"2","key":"898_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187(2):235\u201356. https:\/\/doi.org\/10.1016\/j.cell.2023.11.044.","journal-title":"Cell"},{"key":"898_CR42","doi-asserted-by":"publisher","unstructured":"Cui J, Chen Y, Yang Q, et al. Protosappanin a protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4\/FTH1 axis\u2010dependent ferroptosis. Adv Sci Published online July. 2024;10. https:\/\/doi.org\/10.1002\/advs.202310227.","DOI":"10.1002\/advs.202310227"},{"issue":"7969","key":"898_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura T, Hipp C, Santos Dias Mour\u00e3o A, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619(7969):371\u20137. https:\/\/doi.org\/10.1038\/s41586-023-06255-6.","journal-title":"Nature"},{"key":"898_CR44","doi-asserted-by":"publisher","first-page":"114241","DOI":"10.1016\/j.biopha.2023.114241","volume":"159","author":"L Xu","year":"2023","unstructured":"Xu L, Liu Y, Chen X, Zhong H, Wang Y. Ferroptosis in life: To be or not to be. Biomed Pharmacother. 2023;159:114241. https:\/\/doi.org\/10.1016\/j.biopha.2023.114241.","journal-title":"Biomed Pharmacother"},{"key":"898_CR45","doi-asserted-by":"publisher","unstructured":"Pei J, Pan X, Wei G, Hua Y. Research progress of glutathione peroxidase family (GPX) in redoxidation. Front Pharmacol. 2023;14. https:\/\/doi.org\/10.3389\/fphar.2023.1147414.","DOI":"10.3389\/fphar.2023.1147414"},{"issue":"15","key":"898_CR46","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.3390\/ijms25158423","volume":"25","author":"E Kalinina","year":"2024","unstructured":"Kalinina E. Glutathione-dependent pathways in cancer cells. Int J Mol Sci. 2024;25(15):8423. https:\/\/doi.org\/10.3390\/ijms25158423.","journal-title":"Int J Mol Sci"},{"key":"898_CR47","doi-asserted-by":"publisher","unstructured":"Meng X, Wang Z, Yang Q, et al. Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4. Cell Death Dis. 2024;15(10). https:\/\/doi.org\/10.1038\/s41419-024-06963-5.","DOI":"10.1038\/s41419-024-06963-5"},{"key":"898_CR48","doi-asserted-by":"publisher","unstructured":"Guo F, Ling G, Qiu J, et al. Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK. Chin Med. 2024;19(1). https:\/\/doi.org\/10.1186\/s13020-024-00920-2.","DOI":"10.1186\/s13020-024-00920-2"},{"key":"898_CR49","doi-asserted-by":"publisher","unstructured":"Cao W, He Y, Lan J, et al. FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857\/miR-1290\/GPX4 axis. Cell Death Dis. 2024;15(4). https:\/\/doi.org\/10.1038\/s41419-024-06619-4.","DOI":"10.1038\/s41419-024-06619-4"},{"key":"898_CR50","doi-asserted-by":"publisher","first-page":"177061","DOI":"10.1016\/j.ejphar.2024.177061","volume":"984","author":"X Meng","year":"2024","unstructured":"Meng X, Yang Q, Gao Y, et al. Longikaurin a induces ferroptosis and inhibits glioblastoma progression through DNA methylation - mediated GPX4 suppression. Eur J Pharmacol. 2024;984:177061. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177061.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"898_CR51","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3724\/abbs.2024165","volume":"57","author":"MJ Hou","year":"2025","unstructured":"Hou MJ, Huang X, Zhu BT. Mechanism of RSL3-induced ferroptotic cell death in HT22 cells: Crucial role of protein disulfide isomerase. Acta Biochim Biophys Sin. 2025;57(4):616\u201332. https:\/\/doi.org\/10.3724\/abbs.2024165.","journal-title":"Acta Biochim Biophys Sin"},{"key":"898_CR52","doi-asserted-by":"publisher","unstructured":"Li S, He Y, Chen K et al. RSL3 drives ferroptosis through NF-\u03baB pathway activation and GPX4 depletion in glioblastoma. Sun YR, ed. Oxid Med Cell Longev. 2021;2021(1). https:\/\/doi.org\/10.1155\/2021\/2915019.","DOI":"10.1155\/2021\/2915019"},{"key":"898_CR53","doi-asserted-by":"publisher","unstructured":"Yang J, Mo J, Dai J, et al. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2\/HO-1 signalling pathway in KRAS mutant colorectal cancer. Cell Death Dis. 2021;12(11). https:\/\/doi.org\/10.1038\/s41419-021-04367-3.","DOI":"10.1038\/s41419-021-04367-3"},{"key":"898_CR54","doi-asserted-by":"publisher","first-page":"102426","DOI":"10.1016\/j.redox.2022.102426","volume":"55","author":"H Chen","year":"2022","unstructured":"Chen H, Qi Q, Wu N, et al. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR\/SREBP-1\/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox Biol. 2022;55:102426. https:\/\/doi.org\/10.1016\/j.redox.2022.102426.","journal-title":"Redox Biol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00898-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00898-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:06:46Z","timestamp":1791500806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00898-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00898-x","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In accordance with the Declaration of Helsinki, human tissue collection was approved by the Ethics Committee of Binzhou Medical University Hospital (approval no. KYLL-359) and written informed consent was obtained from all the participants. Animal experiments complied with the ARRIVE guidelines and were approved by the Animal Ethics Committee of Binzhou Medical University Hospital** (Approval No. 20241108-12), following the 3R principles (Replacement, Reduction, Refinement).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"191"}}